ANNEX: Cochlear implant devices (standard package) and replacement CI sound processors1

(replacement package) eligible for subsidy2,3

Company Cochlear implant device (standard Replacement CI sound processor
package) models (replacement package) models
Advanced Bionics AG • HiRes Ultra HiFocus MidScala • Naida CI Q90
• HiRes Ultra HiFocus SlimJ • Naida CI Q30
• Naida CI Q90
• Naida CI Q30

Cochlear Limited • Profile Series Implant • N7 processor

(CI512, CI522, CI532) • N6 processor
• N7 processor • Kanso processor
• N6 processor
• Kanso processor

Med-El • Synchrony Mi1200 CI • Sonnet processor

• Sonnet processor • Rondo processor
• Rondo processor • Rondo 2 processor
• Rondo 2 processor

Neurelec / Oticon • Neuro ZTI CI • Neuro One processor

Medical • Neuro One processor • Neuro Two processor
• Neuro Two processor

Note:
1. Replacement of CI sound processors include replacement with or without upgrade where an upgrade refers
to a change to a later model than currently used by the individual.
2. For children (bilateral cochlear implants and replacement sound processors) and adults (unilateral cochlear
implant), in accordance with the subsidy criteria where applicable.
3. This Annex will be updated as cochlear implant models are revised. Details on the model / package can be
provided upon request.

Last updated on 15 Oct 2020

About the Agency

The Agency for Care Effectiveness (ACE) is the national health technology assessment agency in Singapore residing within the Ministry of Health.
It conducts evaluations to inform the subsidy of health technologies, and produces guidance on the appropriate use of health technologies for
public healthcare institutions in Singapore. This guidance is based on the evidence available to the Committee as at 7 September 2017, and end
2019. This guidance is not, and should not be regarded as a substitute for, professional/medical advice. Please seek the advice of a qualified
healthcare professional on any medical condition. The responsibility for making decisions appropriate to the circumstances of the individual
patient remains with the healthcare professional.

Find out more about ACE at www.ace-hta.gov.sg/about

© Agency for Care Effectiveness, Ministry of Health, Republic of Singapore

All rights reserved. Reproduction of this publication in whole or in part in any material form is prohibited without the prior written permission of
the copyright holder. Application to reproduce any part of this publication should be addressed to:

Principal Head (Evaluation)

Agency for Care
Driving Effectiveness
better decision-making in healthcare
Email: ACE_HTA@moh.gov.sg

In citation, please credit the Ministry of Health, Singapore when you extract and use the information or data from the publication.